Tvardi Therapeutics, Inc. SEC filings TVRD
Tvardi Therapeutics, Inc. has 809 filings in SEC EDGAR's recent list, going back to Dec 6, 2005. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 9, 2026 |
| DEFA14A | Additional proxy material | Apr 22, 2024 | — |
| DEF 14A | Proxy statement | Apr 22, 2024 | Jun 4, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | Jun 4, 2024 |
| DEFA14A | Additional proxy material | Apr 20, 2023 | — |
| DEF 14A | Proxy statement | Apr 20, 2023 | Jun 1, 2023 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Jun 2, 2022 |
| DEFA14A | Additional proxy material | Apr 23, 2021 | — |
| DEF 14A | Proxy statement | Apr 23, 2021 | Jun 3, 2021 |
| DEFA14A | Additional proxy material | Apr 22, 2020 | — |
| DEF 14A | Proxy statement | Apr 22, 2020 | Jun 4, 2020 |
| DEFA14A | Additional proxy material | Apr 24, 2019 | — |
| DEF 14A | Proxy statement | Apr 24, 2019 | Jun 4, 2019 |
| DEFA14A | Additional proxy material | Apr 26, 2018 | — |
| DEF 14A | Proxy statement | Apr 26, 2018 | Jun 6, 2018 |
| DEFA14A | Additional proxy material | May 10, 2017 | — |
| DEF 14A | Proxy statement | May 10, 2017 | Jun 21, 2017 |
| DEFA14A | Additional proxy material | Apr 27, 2016 | — |
| DEF 14A | Proxy statement | Apr 27, 2016 | Jun 15, 2016 |
| DEFA14A | Additional proxy material | Apr 24, 2015 | — |
| DEF 14A | Proxy statement | Apr 24, 2015 | Jun 8, 2015 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TVRD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Sugar Land, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1346830
- Former names
- Cara Therapeutics, Inc. (until Apr 11, 2025); Cara Therapeutics Inc (until Jul 21, 2010)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.